We are live on ! Find out more
CCM

Copeland Capital Management Portfolio holdings

AUM $4.5B
1-Year Est. Return 18.67%
This Fund
S&P 500
This Quarter Est. Return
+3.56%
1 Year Est. Return
+18.67%
3 Year Est. Return
+43.33%
5 Year Est. Return
+60.9%
10 Year Est. Return
+320.99%
AUM
$895M
AUM Growth
+$74.4M
Cap. Flow
+$44.9M
Cap. Flow %
5.01%
Top 10 Hldgs %
21.74%
Holding
205
New
24
Increased
108
Reduced
31
Closed
16

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$16.3M
2
ABT icon
Abbott
ABT
+$10.8M
3
NOV icon
NOV
NOV
+$3.64M
4
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$2.87M
5
NEU icon
NewMarket
NEU
+$2.05M

Sector Composition

Rank Sector Weight
1 Industrials 15.85%
2 Energy 15.71%
3 Healthcare 13.05%
4 Financials 9.89%
5 Consumer Discretionary 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QCOM icon
1
Qualcomm
QCOM
$164B
$21.1M 2.35%
266,116
+10,469
+4% +$832K
ECL icon
2
Ecolab
ECL
$79.8B
$20.1M 2.24%
180,451
+6,589
+4% +$706K
ETP
3
DELISTED
Energy Transfer Partners, L.P.
ETP
$19.7M 2.2%
417,146
+21,026
+5% +$957K
MON
4
DELISTED
Monsanto Co
MON
$19.6M 2.19%
156,855
+17,544
+13% +$2.05M
OKE icon
5
Oneok
OKE
$56.7B
$19.4M 2.17%
285,425
+11,280
+4% +$714K
AMP icon
6
Ameriprise Financial
AMP
$47.8B
$19.2M 2.15%
160,181
+5,701
+4% +$638K
CMCSK
7
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$19M 2.12%
355,790
+27,267
+8% +$1.45M
V icon
8
Visa
V
$677B
$19M 2.12%
359,960
+14,664
+4% +$767K
ARG
9
DELISTED
Airgas Inc
ARG
$18.9M 2.11%
173,279
+23,793
+16% +$2.54M
CVS icon
10
CVS Health
CVS
$135B
$18.7M 2.09%
248,319
-4,488
-2% -$339K
HP icon
11
Helmerich & Payne
HP
$3.34B
$18.5M 2.07%
159,189
-17,484
-10% -$1.92M
CAH icon
12
Cardinal Health
CAH
$53.7B
$18.1M 2.02%
264,247
+42,126
+19% +$2.87M
UNH icon
13
UnitedHealth
UNH
$382B
$17.1M 1.91%
209,468
+191,119
+1,042% +$15M
CHD icon
14
Church & Dwight Co
CHD
$23.7B
$17M 1.9%
485,906
+7,534
+2% +$259K
COV
15
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$16.9M 1.89%
187,516
-38,393
-17% -$2.87M
PSX icon
16
Phillips 66
PSX
$82.9B
$16.9M 1.89%
210,036
+13,646
+7% +$1.12M
OZK icon
17
Bank OZK
OZK
$5.63B
$16.6M 1.86%
497,382
+33,242
+7% +$1.03M
VAL
18
DELISTED
Valspar
VAL
$16.6M 1.85%
217,852
+17,204
+9% +$1.27M
NVO
19
Novo Nordisk
NVO
$228B
$16.6M 1.85%
718,382
+35,664
+5% +$787K
CMI icon
20
Cummins
CMI
$83.6B
$16.5M 1.84%
106,803
+3,326
+3% +$503K
JKHY icon
21
Jack Henry & Associates
JKHY
$11.4B
$16.4M 1.84%
276,747
+11,861
+4% +$677K
CASY icon
22
Casey's General Stores
CASY
$32.1B
$16.2M 1.81%
230,446
+9,955
+5% +$688K
UNP icon
23
Union Pacific
UNP
$174B
$16.1M 1.8%
161,774
+13,720
+9% +$1.33M
PII icon
24
Polaris
PII
$3.83B
$16.1M 1.8%
123,895
+10,221
+9% +$1.35M
AFSI
25
DELISTED
AmTrust Financial Services, Inc.
AFSI
$16M 1.79%
767,402
+31,194
+4% +$640K

Similar funds

Copeland Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Copeland Capital Management held 205 positions worth $895M, up 9.1% from $821M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Copeland Capital Management deployed $44.9M of net new capital in Q2 2014, opening 24 new positions and adding to 108 existing holdings. Its largest new stake was DNOW Inc: 37,070 shares worth $1.34M.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, up from 15% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was Accenture, an estimated $16.3M trimmed.

  • Copeland Capital Management's largest Q2 2014 buy was DNOW Inc: 37,070 shares worth $1.34M.
  • Copeland Capital Management added most to UnitedHealth in Q2 2014, an estimated $15M increase.
  • Copeland Capital Management's biggest Q2 2014 reduction was Accenture, cutting an estimated $16.3M.
  • Copeland Capital Management fully exited Abbott in Q2 2014, selling an estimated $10.8M.
  • Copeland Capital Management's ten largest holdings make up 22% of its $895M portfolio in Q2 2014.
  • Copeland Capital Management opened 24 new positions and closed 16 in Q2 2014.
  • Copeland Capital Management's portfolio value rose 9.1% quarter-over-quarter to $895M.

Based on Copeland Capital Management's 13F filing for Q2 2014, filed 12 Aug 2014.